cover image: Waiting for treatment

Premium

20.500.12592/9wdgc5

Waiting for treatment

8 Oct 2015

CBCN is taking the lead on raising awareness of the need for equitable access to drug treatments for Delays can occur at any of the four main stages during the metastatic breast cancer in all regions of Canada. [...] WAITING FOR TREATMENT: TIMELY EQUITABLE ACCESS TO DRUGS FOR METASTATIC BREAST CANCER – 2015 3 INTRODUCTION any Canadians are shocked to learn that drugs The Canadian Breast Cancer Network champions the Mapproved for sale in Canada with demonstrated issues of Canadians living with metastatic breast cancer to efficacy are often not covered by provincial decision-makers and the general public. [...] The Living Legacy campaign highlights identified metastatic breast cancer as a priority issue, and has the urgent need to ensure that the voices and experiences been actively working to raise awareness of metastatic breast of Canadians living with metastatic breast cancer are being cancer and advocate for the development of more resources, leveraged to inform health care decision-making at all lev [...] For these patients, the longest and the system causing the greatest lags, the vast differences in wait most problematic delays in the metastatic drug review system times for new treatments by province and the jurisdictions most occur at the post-pCODR stage. [...] It is important to note, particularly in the case of elapsed between the issuing of the Notice of Compliance Kadcyla, which is the newest drug to enter the market, that from Health Canada to the Notification to Implement issued these drugs are still undergoing review in several provinces by pCODR, which varied between three and eight months and that these wait times are therefore just a snapshot o
health drugs cancer chemicals health insurance medicine health care prescription drugs drug approval breast neoplasms therapy chemotherapy breast clinical medicine antineoplastic agents provinces breast cancer health treatment medical drugs province pharmaceutical bevacizumab estrogen her2 herceptin perjeta kadcyla metastasis metastatic breast cancer exemestane

Authors

Dunbrack, Janet, Faucette, Craig, Chari, Niya

ISBN
9780992028886
Pages
36
Published in
Ottawa, Ontario

Related Topics

All